Abstract
Background: To determine the prevalence and presentation of ocular manifestations among patients who presented with pre-eclampsia and eclampsia at a tertiary hospital. Methods: A cross-sectional descriptive study was conducted at Muhimbili National Hospital (MNH). All patients with pre-eclampsia and eclampsia who met the inclusion criteria during the study period were included. A total of 113 patients were recruited. Data collection was done for six months which involved; case note review and ocular examination. Findings were recorded in structured questionnaires. Computer software SPSS version 20 was used for descriptive analysis of the gathered data. The results were summarized in frequency tables, bar and pie charts. inferential statistics were performed and a p<0.05 was considered significant.Results: The patients age range was 18-49 years with a mean age of 29.26 years. Forty five (39.8%) patients had pre-eclampsia while 68 (60.2%) had eclampsia. The overall prevalence of visual disturbances was 51 (45.1%). Poor vision occured in 39 (35.4%) patients followed by photopsia 15.9% and diplopia 2.7%. Fundus findings were; papilledema 28.3%, retinal edema 19.5%, cotton-wool spots 18.6%, arteriolar narrowing 17.7%, flame-shaped haemorrhages 8% and macular edema 5.3%. On admision 39 (35.4%) patients had impaired vision with a corrected visual-acuity of <6/18. At discharge only 13.3% had impaired vision. The mean visual recovery time was 8.5±1.2 days.Conclusion: The prevalence of visual disturbances among patients with pre-eclampsia and eclampsia at MNH was significantly high. Majority presented with blurred vision and it was temporary in 86.7% of patients. Recommendation: Measures to create awareness among health personnel regarding sudden visual loss among pregnant women as an alarming sign of pre-eclampsia are recommended. Obstetricians need to assess vision and fundus examination in these patients and refer them for ophthalmic care accordingly.
References
World Health Organization. Maternal mortality: Fact sheet 2015. 2. Samra KA. The eye and visual system in the preeclampsia. Saudi J Ophthalmol. 2013; 27(1):51–53. 3. The American College of Obstetricians and Gynecologists: Practice Bulletin No. 33: Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol. 2002; 99(1):159–167. 4. Matthews Z. Make every mother and child count. World Health. 2005 p. 409–411. 5. Osungbade KO, Ige OK. Public health perspectives of preeclampsia in developing countries: implication for health system strengthening. J Pregnancy. 2011; 2011:481-495. 6. Lelia Duley. Pre-eclampsia and the hypertensive disorders of pregnancy. Br Med Bull. 2003; 67(1):161–176. 7. Charlene T, Hannah D, Andrew K, Annemarie HP. The incidence of preeclampsia and eclampsia and associated maternal mortality in Australia from population. Am J Obstet Gynecol. 2013; 208(6):476.e1–476.e5. 8. Urassa DP, Carlstedt A, Nyström L, Massawe SN. Eclampsia in Dar es Salaam, Tanzania. The incidence, outcome, and the role of antenatal care. Acta Obs Gynecol Scand. 2006; 85(5):571–578. 9. Kidanto HL, Wangwe P, Kilewo CD, Nystrom L, Lindmark G. Improved quality of management of eclampsia patients through criteria based audit at Muhimbili National Hospital, Dar es Salaam, Tanzania. Bridging the quality gap. BMC Pregnancy Childbirth. 2012; 12:134. 10. Ryan SJ. Pregnancy and retinal disease. Retina. 1994; 2:1393–403. 11. France J. Characteristics of symptoms of imminent eclampsia: A case referent study from a tertiary hospital in Tanzania. Open J Obstet Gynecol. 2012; 2(September):311–317. 12. Do DV, Rismondo V, Nguyen QD. Reversible cortical blindness in preeclampsia. Am J Ophthalmol. 2002; 134:916–918. 13. Mitas RL. Acute cortical blindness in preeclampsia. Ginekol Pol. 2012; 83(6):469–472. 14. National Bureau of Statistics (NBS). Youth in Tanzania. Tanzania Demographic and Health Survey 2010 p. 5. 15. Odegård RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Risk factors and clinical manifestations of pre-eclampsia. Brit J Obstet Gynecol. 2000; 107(11):1410–1416. 7J Ophthalmol East Cent & S Afr. July 2016; 20(1): 2-716.
J Ophthalmol East Cent & S Afr. July 2016; 20(1)
J Ophthalmol East Cent & S Afr. July 2016; 20(1): 2-7
Cunningham FG, Fernandez CO, Hernandez C.
Blindness associated with preeclampsia and eclampsia.
Am J Obstet Gynecol. 1995; 172:1291–1298.
Shah AK, Rajamani WJ. Eclampsia: a neurological
perspective. J Neurol Sci. 2008; 271(1-2):158.
Rajaram GN. Sudden bilateral loss of vision postpartum.
J Indian Acad Clin Med. 2002; 3:213–214.
Swende TZ, Abwa T. Reversible blindness in
fulminating preeclampsia. Ann Afr Med. 2009;
(3):189–191.
Schreyer P, Tzadok J SD. Fluorescein angiography
in preeclamptic patients. Curr Opin Obstet Gynecol.
; 4(1):129–150.
Jyotsana, Sharma AK BS. Reversible blindness in
severe preeclampsia and eclampsia. JK Sci. 2004;
:43–45.
Garg A, Wapner RJ, Ananth CV, Dale E, Tsang
SH, Lee W, Allikmets RBS. Choroidal and retinal
thickening in severe preeclampsia. Invest Ophthalmol
Vis Sci. 2014; 55(9):5723–5729.
Neudorfer M, Spierer O, Goder M, Newman H, Barak
S, Barak A, et al. The prevalence of retinal and optical
coherence tomography findings in preeclamptic
women. Retina. 2014; 34:1376–1383.
Bergman L, Akhter T, Wikström AK, Wikström J,
Naessen T ÅH. Plasma levels of S100B in preeclampsia
and association with possible central nervous system
effects. Am J Hypertens. 2014; 27(8):1105–1111.